Innoviz Technologies Ltd.
جودة البيانات: 100%
KWD 0.68
▲
KWD 0.03
(4.20%)
القيمة السوقية: 140.60 M
السعر
KWD 0.66
القيمة السوقية
140.60 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue grew 78.18% annually over 5 years — strong growth
Negative free cash flow of -52.17 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 48.82%
Capital efficient — spends only 7.71% of revenue on capex
النمو
Revenue Growth (5Y)
78.18%
أعلى من متوسط القطاع (1.82%)
Revenue (1Y)127.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-74.18%
أقل من متوسط القطاع (-54.47%)
ROIC-44.27%
Net Margin-123.06%
Op. Margin-122.95%
الأمان
Debt / Equity
N/A
Current Ratio3.18
Interest CoverageN/A
التقييم
PE (TTM|NTM)
-2.07 | -2.90
أقل من متوسط القطاع (-1.49)
P/B Ratio1.57
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -2.1 | -1.5 |
| P/B | 1.6 | 1.6 |
| ROE % | -74.2 | -54.5 |
| Net Margin % | -123.1 | -41.5 |
| Rev Growth 5Y % | 78.2 | 1.8 |
| D/E | — | 0.3 |
السعر المستهدف للمحللين
2 محللين
Buy
الحالي
KWD 0.68
المستهدف
KWD 2.28
KWD 1.25
KWD 2.28
KWD 3.30
التوقعات
مكرر الربحية المستقبلي
-2.90
ربحية السهم المستقبلية
-KWD 0.23
الإيرادات المقدّرة
102.96 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
-KWD 0.23
-KWD 0.26 – -KWD 0.21
|
102.96 M | 3 |
| FY2026 | — | 98.16 M | 3 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.08
-KWD 0.08 – -KWD 0.08
|
15.00 M | 1 |
| 2026 Q1 |
-KWD 0.09
-KWD 0.09 – -KWD 0.09
|
13.67 M | 1 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.08 | -KWD 0.10 | -30.4% |
| Q32025 | -KWD 0.08 | -KWD 0.08 | -2.7% |
| Q22025 | -KWD 0.09 | -KWD 0.09 | +1.3% |
| Q12025 | -KWD 0.10 | -KWD 0.07 | +26.6% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 127.00% | Revenue Growth (3Y) | 62.45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 78.18% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 55.09 M | Net Income (TTM) | -67.80 M |
| ROE | -74.18% | ROA | -44.87% |
| Gross Margin | 23.43% | Operating Margin | -122.95% |
| Net Margin | -123.06% | Free Cash Flow (TTM) | -52.17 M |
| ROIC | -44.27% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3.18 |
| Interest Coverage | N/A | Asset Turnover | 0.36 |
| Working Capital | 70.09 M | Tangible Book Value | 89.67 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.07 | Forward P/E | -2.90 |
| P/B Ratio | 1.57 | P/S Ratio | 2.55 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1.37 | Fwd Earnings Yield | N/A |
| FCF Yield | -37.10% | ||
| Market Cap | 140.60 M | Enterprise Value | 132.71 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.34 | Revenue / Share | 0.26 |
| FCF / Share | -0.24 | OCF / Share | -0.22 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 7.71% | FCF Conversion | 76.95% |
| SBC-Adj. FCF | -85.61 M | Growth Momentum | 48.82 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 55.09 M | 24.27 M | 20.88 M | 6.03 M | 5.47 M |
| Net Income | -67.80 M | -94.76 M | -123.45 M | -126.87 M | -153.56 M |
| EPS (Diluted) | -0.34 | -0.57 | -0.84 | -0.94 | — |
| Gross Profit | 12.91 M | -1.16 M | -11.61 M | -8.76 M | -5.02 M |
| Operating Income | -67.73 M | -101.92 M | -132.60 M | -133.35 M | -157.65 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 56.48 M | 73.82 M | 92.68 M | 95.11 M | 93.34 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 5.87 M | 7.79 M | 9.19 M | 7.47 M | 3.96 M |
| Interest Expense | — | — | — | — | — |
| Income Tax | 171,000.0 | 167,000.0 | 642,000.0 | 325,000.0 | 284,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 138.45 M | 132.05 M | 219.23 M | 255.43 M | 327.22 M |
| Total Liabilities | — | — | — | — | — |
| Shareholders' Equity | 77.72 M | 78.93 M | 153.29 M | 192.02 M | 298.80 M |
| Total Debt | — | — | — | — | 0.0 |
| Cash & Equivalents | 8.64 M | 25.37 M | 26.28 M | 55.72 M | 23.64 M |
| Current Assets | 90.23 M | 82.62 M | 160.46 M | 187.55 M | 274.43 M |
| Current Liabilities | 31.43 M | 27.77 M | 37.23 M | 32.43 M | 21.67 M |
{"event":"ticker_viewed","properties":{"ticker":"INVZ","listing_kind":"stock","pathname":"/stocks/invz","exchange":"NASDAQ","country":"US"}}